Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real‐world evidence in our current therapeutic era

Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real‐world evidence in our current therapeutic era

Abstract Background of the study AML classification tools have been developed to stratify the risk at AML diagnosis. There is a need to evaluate these tools in the current therapeutic era. Cohort characteristics In this retrospective study, we compared five classifiers: ELN 2017, ELN 2022, ALFA clas...

Full description

Bibliographic Details
Main Authors: Alexandre Iat, Michael Loschi, Sami Benachour, Anne Calleja, Edmond Chiche, Isabelle Sudaka, Danièle Aquaronne, Corinne Ferrero, Laurène Fenwarth, Alice Marceau, Elise Fournier, Berengere Dadone‐Montaudie, Thomas Cluzeau
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Cancer Medicine
Subjects:
AML
classifier
ELN
prognosis
WHO
Online Access:https://doi.org/10.1002/cam4.7103

Internet

https://doi.org/10.1002/cam4.7103

Similar Items